Literature DB >> 27147710

Efficacy of abatacept for IgG4-related disease over 8 months.

Motohisa Yamamoto1, Hiroki Takahashi1, Kenichi Takano2, Yui Shimizu1, Nodoka Sakurai1, Chisako Suzuki1, Yasuyoshi Naishiro1, Hidetaka Yajima3, Teruhito Awakawa4, Tetsuo Himi2, Hiroshi Nakase1.   

Abstract

Keywords:  DMARDs (biologic); Sjøgren's Syndrome; T Cells

Mesh：

Substances：

Year:  2016        PMID： 27147710     DOI： 10.1136/annrheumdis-2016-209368

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  IgG4-Related Disease: Beyond Glucocorticoids.

Authors:  Mitsuhiro Akiyama; Tsutomu Takeuchi
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

Review 2.  Diagnostic and treatment workup for IgG4-related disease.

Authors:  Mary Abraham; Arezou Khosroshahi
Journal:  Expert Rev Clin Immunol       Date:  2017-07-24       Impact factor: 4.473

Review 3.  The Immunologic Paradoxes of IgG4-Related Disease.

Authors:  Xiao Xiao; Min Lian; Weici Zhang; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 4.  Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies.

Authors:  Cory A Perugino; Hamid Mattoo; Vinay S Mahajan; Takashi Maehara; Zachary S Wallace; Shiv Pillai; John H Stone
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

5.  Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study.

Authors:  Mark A Matza; Cory A Perugino; Liam Harvey; Ana D Fernandes; Zachary S Wallace; Hang Liu; Hugues Allard-Chamard; Shiv Pillai; John H Stone
Journal:  Lancet Rheumatol       Date:  2021-12-01

6.  Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4‑related ophthalmic disease.

Authors:  Huimin Yang; Ruili Wei; Qiang Liu; Yongheng Shi; Jin Li
Journal:  Mol Med Rep       Date:  2017-10-12       Impact factor: 2.952

Review 7.  Immunoglobulin G4-related kidney diseases: An updated review.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Nephrol       Date:  2018-01-06

8.  Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.

Authors:  Mikael Ebbo; Matthieu Patient; Aurelie Grados; Matthieu Groh; Julien Desblaches; Eric Hachulla; David Saadoun; Sylvain Audia; Aude Rigolet; Benjamin Terrier; Antoinette Perlat; Constance Guillaud; Frederic Renou; Emmanuelle Bernit; Nathalie Costedoat-Chalumeau; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 9.  Recent advances in understanding and managing IgG4-related disease.

Authors:  Anna R Wolfson; Daniel L Hamilos
Journal:  F1000Res       Date:  2017-02-23

10.  Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Authors:  Mikael Ebbo; Aurélie Grados; Maxime Samson; Matthieu Groh; Anderson Loundou; Aude Rigolet; Benjamin Terrier; Constance Guillaud; Clarisse Carra-Dallière; Frédéric Renou; Agnieszka Pozdzik; Pierre Labauge; Sylvain Palat; Jean-Marie Berthelot; Jean-Loup Pennaforte; Alain Wynckel; Céline Lebas; Noémie Le Gouellec; Thomas Quémeneur; Karine Dahan; Franck Carbonnel; Gaëlle Leroux; Antoinette Perlat; Alexis Mathian; Patrice Cacoub; Eric Hachulla; Nathalie Costedoat-Chalumeau; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.